Investor Presentaiton
1
MAX
Healthcare
Strong cash flow and balance sheet to fund future growth plans
Strong and growing cash
flow generation
•
•
Strong revenue growth driven by increasing health insurance penetration, better patient mix, increasing
ARPOB, growth in medical tourism and focus on tower specialties
EBITDA growth faster than revenue growth driven by operating leverage
-
Q4 FY21 contribution margins stood at 60%
Redeployment of funds to higher ROCE projects shall also generate incremental cash flows
Ability to leverage
balance sheet
.
.
Net debt of the company reduced from INR 2,116 Cr as on June 30, 2020 to INR 459 Cr as on June 30,
2021
Predictable and growing free cash flow gives meaningful headroom to leverage balance sheet for
growth
As on June 30, 2021, Net Debt / Operating EBITDA* stood at 0.45
Massive opportunity to
invest incremental
capital at attractive rates
of return
*Rolling 12 months EBITDA
•
•
Strong free cash flows and low debt provides adequate headroom to expand through brownfield,
greenfield and M&A
Leverage brand, network and clinical excellence to deploy capital at extremely attractive returns on
capital employed
-
Q1 FY22 ROCE stood at 28.5%
15View entire presentation